Michael A Palladino

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.

Hiroshi Yasui, Paul Richardson, Benjamin Nicholson, 2005, Cancer cell.

Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs

Jeffrey Weiss, S. Neuteboom, T. Chao, 2011, Journal of Pharmacology and Experimental Therapeutics.

Anti-TNF-alpha therapies: the next generation.

Emmanuel A Theodorakis, Lyle L Moldawer, L. Moldawer, 2003, Nature reviews. Drug discovery.